Published in Stem Cell Res on July 23, 2011
Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells. Prog Biophys Mol Biol (2012) 1.00
Potential for pharmacological manipulation of human embryonic stem cells. Br J Pharmacol (2013) 0.85
Cardiomyocyte regeneration. Cells (2013) 0.80
Assessing developmental roles of MKK4 and MKK7 in vitro. Commun Integr Biol (2012) 0.79
Prospective in vitro models of channelopathies and cardiomyopathies. Stem Cells Int (2012) 0.79
Analysis of induced pluripotent stem cells carrying 22q11.2 deletion. Transl Psychiatry (2016) 0.77
EBIO Does Not Induce Cardiomyogenesis in Human Pluripotent Stem Cells but Modulates Cardiac Subtype Enrichment by Lineage-Selective Survival. Stem Cell Reports (2017) 0.75
Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells (2013) 0.75
Coordinated Proliferation and Differentiation of Human-Induced Pluripotent Stem Cell-Derived Cardiac Progenitor Cells Depend on Bone Morphogenetic Protein Signaling Regulation by GREMLIN 2. Stem Cells Dev (2017) 0.75
Whole-genome mapping of histone H3 Lys4 and 27 trimethylations reveals distinct genomic compartments in human embryonic stem cells. Cell Stem Cell (2007) 7.05
Generation of induced pluripotent stem cells from human cord blood. Cell Stem Cell (2009) 2.78
The generation of six clinical-grade human embryonic stem cell lines. Cell Stem Cell (2007) 1.75
Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK. Differentiation (2007) 1.66
An analogy between the evolution of drug resistance in bacterial communities and malignant tissues. Nat Rev Cancer (2011) 1.58
Chemically defined medium supporting cardiomyocyte differentiation of human embryonic stem cells. Differentiation (2008) 1.56
Insulin redirects differentiation from cardiogenic mesoderm and endoderm to neuroectoderm in differentiating human embryonic stem cells. Stem Cells (2007) 1.38
A physical sciences network characterization of non-tumorigenic and metastatic cells. Sci Rep (2013) 1.33
Induced pluripotent stem cell (iPSC)-derived Flk-1 progenitor cells engraft, differentiate, and improve heart function in a mouse model of acute myocardial infarction. Eur Heart J (2011) 1.29
Differentiation and lineage selection of mouse embryonic stem cells in a stirred bench scale bioreactor with automated process control. Biotechnol Bioeng (2005) 1.28
Survival and maturation of human embryonic stem cell-derived cardiomyocytes in rat hearts. J Mol Cell Cardiol (2007) 1.23
Up-scaling single cell-inoculated suspension culture of human embryonic stem cells. Stem Cell Res (2010) 1.19
Murine and human pluripotent stem cell-derived cardiac bodies form contractile myocardial tissue in vitro. Eur Heart J (2012) 1.16
Cardiomyocyte production in mass suspension culture: embryonic stem cells as a source for great amounts of functional cardiomyocytes. Tissue Eng Part A (2008) 1.12
Suspension culture of human pluripotent stem cells in controlled, stirred bioreactors. Tissue Eng Part C Methods (2012) 1.11
Global expression profile of highly enriched cardiomyocytes derived from human embryonic stem cells. Stem Cells (2009) 1.09
Scalable platform for human embryonic stem cell differentiation to cardiomyocytes in suspended microcarrier cultures. Tissue Eng Part C Methods (2010) 1.04
Transferrin receptor-dependent cytotoxicity of artemisinin-transferrin conjugates on prostate cancer cells and induction of apoptosis. Cancer Lett (2008) 1.04
Electrical stimulation promotes maturation of cardiomyocytes derived from human embryonic stem cells. J Cardiovasc Transl Res (2013) 0.96
Cardiomyocyte enrichment from human embryonic stem cell cultures by selection of ALCAM surface expression. Regen Med (2009) 0.94
Considerations in designing systems for large scale production of human cardiomyocytes from pluripotent stem cells. Stem Cell Res Ther (2014) 0.92
The use of agarose microwells for scalable embryoid body formation and cardiac differentiation of human and murine pluripotent stem cells. Biomaterials (2013) 0.90
Directing cardiomyogenic differentiation of human pluripotent stem cells by plasmid-based transient overexpression of cardiac transcription factors. Stem Cells Dev (2013) 0.89
Autogeneic feeders for the culture of undifferentiated human embryonic stem cells in feeder and feeder-free conditions. Methods Cell Biol (2008) 0.86
The benefit of preterm birth at tertiary care centers is related to gestational age. Am J Obstet Gynecol (2003) 0.84
Cleavage of E-cadherin and β-catenin by calpain affects Wnt signaling and spheroid formation in suspension cultures of human pluripotent stem cells. Mol Cell Proteomics (2014) 0.84
A practical synthesis of Rho-Kinase inhibitor Y-27632 and fluoro derivatives and their evaluation in human pluripotent stem cells. Org Biomol Chem (2011) 0.83
Fast and efficient multitransgenic modification of human pluripotent stem cells. Hum Gene Ther Methods (2014) 0.82
Lentiviral labeling reveals three germ layer differentiation potential of a single unrestricted somatic stem cell from human cord blood. Exp Hematol (2010) 0.82
The time is right: proteome biology of stem cells. Cell Stem Cell (2008) 0.80
Successful re-endothelialization of a perfusable biological vascularized matrix (BioVaM) for the generation of 3D artificial cardiac tissue. Basic Res Cardiol (2014) 0.80
Time-resolved video analysis and management system for monitoring cardiomyocyte differentiation processes and toxicology assays. Biotechnol J (2014) 0.79
Differentiation of human embryonic stem cells to cardiomyocytes on microcarrier cultures. Curr Protoc Stem Cell Biol (2012) 0.79
Substantial early loss of induced pluripotent stem cells following transplantation in myocardial infarction. Artif Organs (2014) 0.79
Proteome biology of stem cells. Stem Cell Res (2007) 0.78
Pushing the envelope in tissue engineering: ex vivo production of thick vascularized cardiac extracellular matrix constructs. Tissue Eng Part A (2015) 0.78
Proteome biology of stem cells: a new joint HUPO and ISSCR initiative. Mol Cell Proteomics (2008) 0.78
Tri-substituted imidazole analogues of SB203580 as inducers for cardiomyogenesis of human embryonic stem cells. Bioorg Med Chem Lett (2013) 0.78
Genomic profiling of developing cardiomyocytes from recombinant murine embryonic stem cells reveals regulation of transcription factor clusters. Physiol Genomics (2009) 0.77
The Promise and Therapeutic Potential of Human ES and iPS Cells. Stem Cells Int (2011) 0.77
Managing particulates in cellular therapy. Cytotherapy (2012) 0.76
Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells. World J Stem Cells (2013) 0.75
Stem cell derived in vivo-like human cardiac bodies in a microfluidic device for toxicity testing by beating frequency imaging. Lab Chip (2015) 0.75